Skip to main content

FDA recall, , Moderate risk

THERANICA BIOELECTRONICS Nerivio Infinity

Nerivio Infinity has a potential for a thermal-runway event during charging, resulting in smoke and odor.

What happened

THERANICA BIOELECTRONICS LTD of Netanya, Israel began a recall of Nerivio Infinity on March 23, 2026, due to a potential for the batter to have a thermal-runway event during charging, resulting in smoke and odor. The FDA added the recall to its Enforcement Report on July 31, 2026, and it was in the weekly enforcement report on August 12, 2026. The product is distributed through a 3PL warehouse to DME distributors or specialty pharmacies for shipment to end-users.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Match the model number and UDI-DI listed under your product.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. Nerivio Infinity

    Model number
    • FGD000100
    UDI-DI
    • 7290017578118

Recall details

Company began the recall
Sold in

The product's entry point to the US is a 3PL warehouse from which it is being shipped to DME distributors or specialty pharmacy who perform the shipment to the end-user

Company
THERANICA BIOELECTRONICS LTDNetanya, Israel
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
99307
Recall number
Z-2855-2026
Quantity recalled
11,886 units

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 25, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)